홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

Azane;hydrate → HCID 20030947, 화합물

HRID 232214
노트
인쇄 미리보기

반응식

HRID 232214 반응식
[CH2:1]([O:8][C:9]([NH:11][CH:12]1[CH:16]([C:17](OC)=[O:18])[O:15][NH:14][C:13]1=[O:21])=[O:10])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.O.[NH3:23]>>[CH2:1]([O:8][C:9]([NH:11][CH:12]1[CH:16]([C:17](=[O:18])[NH2:23])[O:15][NH:14][C:13]1=[O:21])=[O:10])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

3

반응물 2

HCID 12896473Azane;hydrateHCID 20030921HCID 20030921, 화합물

생성물 1

HCID 20030947HCID 20030947, 화합물

실험 절차

In 2.4 ml of concentrated ammonia water was dissolved 150 mg of 4-benzyloxycarbonylamino-5-methoxycarbonyl-3-isoxazolidinone (mixture of 4,5-cis compound and -trans compound). The solution was left standing at room temperature for 20 minutes, which was concentrated to dryness under reduced pressure. Ether was added to the concentrate to give 138 mg of 4-benzyloxycarbonylamino-5-carbamoyl-3-isoxazolidinone as crystals.

후처리

  1. waitThe solution was left
  2. concentrationwhich was concentrated to dryness under reduced pressure
  3. additionEther was added to the
  4. concentrationconcentrate

출처 및 근거

ORD 기록
ord-eee281fc6c844eb4bdc5aa560c1c873c
출처 데이터셋
uspto-grants-1989_07
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US04851422

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트